Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Glutamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.91 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.91 |
| ▸ | BLM | P54132 | 1/20 | 0.91 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.91 |
| ▸ | GSR | P00390 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | GRM8 | O00222 | 2/20 | 0.62 |
| ▸ | GRM6 | O15303 | 2/20 | 0.62 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.62 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.62 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.62 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.62 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.62 |
| ▸ | GRM5 | P41594 | 1/20 | 0.62 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.62 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.62 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.62 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glutamine SCHEMBL7176752 | 1.00 | KMT2A (0.91) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL7453 | 0.95 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL994966 | 0.95 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL7452 | 0.95 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL411588 | 0.95 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL411575 | 0.95 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL5580393 | 0.95 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL411170 | 0.95 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL1332116 | 0.95 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL711605 | 0.95 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230307094-A1 | METHOD FOR PREDICTING CANCER PROGNOSIS AND MODEL THEREFOR | NATIONAL CHENG KUNG UNIVERSITY (TW) | 2023-09-28 | — | — | US | disclosed |
| EP-4224479-A1 | METHOD FOR PREDICTING CANCER PROGNOSIS AND MODEL THEREFOR | National Cheng Kung University Hospital (TW) | 2023-08-09 | — | — | EP | disclosed |
| EP-0754192-B1 | CIRCULARLY PERMUTED LIGANDS AND CIRCULARLY PERMUTED CHIMERIC MOLECULES | US GOV HEALTH & HUMAN SERV (US) | 2003-01-29 | — | — | EP | disclosed |
| US-6011002-A | NOVEL MODIFIED FORMS OF LIGANDS SUCH AS INTERLEUKIN 4 (IL4) WHEREIN THE AMINO AND CARBOXY ENDS ARE JOINED TOGETHER THROUGH A LINKER, AND NEW AMINO AND CARBOXY TERMINAL ENDS ARE FORMED. MODIFIED LIGANDS ARE AS FULLY ACTIVE AS THE ORIGINAL LIGANDS. | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-01-04 | — | — | US | disclosed |
| EP-0754192-A1 | CIRCULARLY PERMUTED LIGANDS AND CIRCULARLY PERMUTED CHIMERIC MOLECULES | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services (US) | 1997-01-22 | — | — | EP | disclosed |
| WO-1995027732-A2 | CIRCULARLY PERMUTED LIGANDS AND CIRCULARLY PERMUTED CHIMERIC MOLECULES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-10-19 | — | — | WO | disclosed |